{"transactions":[{"id":731703,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T21:00:19.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":25319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 25,319 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":25319,"derivative":{"exercise_price":13.55,"expiration_date":"2026-06-16","underlying":"Common Stock","underlying_shares":25319},"source":{"system":"sec-edgar","filing":"0001193125-26-276059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000119312526276059/ownership.xml","form_type":"4"}},{"id":739254,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T22:13:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":13980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":13980,"derivative":{"exercise_price":26.82,"expiration_date":"2036-06-10","underlying":"Ordinary Shares","underlying_shares":13980},"source":{"system":"sec-edgar","filing":"0000904454-26-000352","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445426000352/edgar.xml","form_type":"4"}},{"id":739253,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T22:13:11.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":1993,"price":27.06,"value":53930.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote."}],"balance_after":39747,"source":{"system":"sec-edgar","filing":"0000904454-26-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445426000352/edgar.xml","form_type":"4"}},{"id":739252,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T22:13:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":7550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":41740,"source":{"system":"sec-edgar","filing":"0000904454-26-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445426000352/edgar.xml","form_type":"4"}},{"id":1102410,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-24T21:34:16.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":2112,"price":14.45,"value":30518.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34190,"source":{"system":"sec-edgar","filing":"0000904454-25-000328","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445425000328/edgar.xml","form_type":"4"}},{"id":1109469,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:09:05.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":38513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date"}],"balance_after":38513,"derivative":{"exercise_price":8.95,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":38513},"source":{"system":"sec-edgar","filing":"0000950170-25-086721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000095017025086721/ownership.xml","form_type":"4"}},{"id":1111085,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:27:52.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15630,"derivative":{"exercise_price":16.22,"expiration_date":"2035-06-11","underlying":"Ordinary Shares","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0000904454-25-000305","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445425000305/edgar.xml","form_type":"4"}},{"id":1111084,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-13T20:27:52.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":7970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":36302,"source":{"system":"sec-edgar","filing":"0000904454-25-000305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445425000305/edgar.xml","form_type":"4"}},{"id":1471754,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:10:51.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":15840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15840,"derivative":{"exercise_price":4.57,"expiration_date":"2034-06-19","underlying":"Ordinary Shares","underlying_shares":15840},"source":{"system":"sec-edgar","filing":"0000904454-24-000403","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445424000403/edgar.xml","form_type":"4"}},{"id":1471753,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-21T21:10:51.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":8080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":28332,"source":{"system":"sec-edgar","filing":"0000904454-24-000403","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445424000403/edgar.xml","form_type":"4"}},{"id":1476917,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T23:35:29.000Z","date":"2024-06-13","kind":"sale","planned":false,"acquired":false,"shares":2229,"price":5.12,"value":11412.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.12 to $5.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20252,"source":{"system":"sec-edgar","filing":"0000904454-24-000373","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445424000373/edgar.xml","form_type":"4"}},{"id":1492530,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-04T17:25:43.000Z","date":"2024-06-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Arrangement Agreement, dated as of March 18, 2024 (the \"Arrangement Agreement\"), by and among the Issuer, AstraZeneca AB, a public company with limited liability (Aktiebolag) incorporated under the laws of Sweden (\"Parent\") and 15863210 Canada Inc., a corporation formed under the Canada Business Corporations Act (\"Purchaser\"), Purchaser acquired all of the issued and outstanding common shares of the Issuer (collectively, the \"Shares\") effective as of 12:01 a.m. Toronto time on June 4, 2024 (the \"Effective Time\"). Following the Effective Time, each Share outstanding immediately prior to the Effective Time was assigned and transferred by the holder thereof to Purchaser in exchange for (i) US$21.00 in cash (the \"Cash Consideration\") plus (ii) one contingent value right (each, a \"CVR\") representing the contingent right to receive a cash payment equal to US$3.00, in each case subject to applicable tax withholdings and other source deductions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option to purchase Shares granted (each, an \"Option\") with an exercise price that is less than the Cash Consideration and outstanding immediately prior to the Effective Time, whether vested or unvested, was assigned, transferred and surrendered by the holder thereof to the Issuer and thereafter cancelled in consideration for (A) a cash payment by or on behalf of the Issuer equal to the number of Shares into which such Option is then exercisable multiplied by the amount, if any, by which the Cash Consideration exceeds the exercise price per Share of such Option and (B) one CVR with respect to each Share into which such Option is then exercisable, in each case subject to applicable tax withholdings and other source deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option to purchase Shares granted (each, an \"Option\") with an exercise price that is less than the Cash Consideration and outstanding immediately prior to the Effective Time, whether vested or unvested, was assigned, transferred and surrendered by the holder thereof to the Issuer and thereafter cancelled in consideration for (A) a cash payment by or on behalf of the Issuer equal to the number of Shares into which such Option is then exercisable multiplied by the amount, if any, by which the Cash Consideration exceeds the exercise price per Share of such Option and (B) one CVR with respect to each Share into which such Option is then exercisable, in each case subject to applicable tax withholdings and other source deductions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option to purchase Shares granted (each, an \"Option\") with an exercise price that is less than the Cash Consideration and outstanding immediately prior to the Effective Time, whether vested or unvested, was assigned, transferred and surrendered by the holder thereof to the Issuer and thereafter cancelled in consideration for (A) a cash payment by or on behalf of the Issuer equal to the number of Shares into which such Option is then exercisable multiplied by the amount, if any, by which the Cash Consideration exceeds the exercise price per Share of such Option and (B) one CVR with respect to each Share into which such Option is then exercisable, in each case subject to applicable tax withholdings and other source deductions."}],"balance_after":0,"derivative":{"exercise_price":4.16,"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000950170-24-068892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000095017024068892/ownership.xml","form_type":"4"}},{"id":1513852,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T21:40:08.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":15618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 15,618 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date."}],"balance_after":15618,"derivative":{"exercise_price":26.72,"expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":15618},"source":{"system":"sec-edgar","filing":"0000950170-24-061228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000095017024061228/ownership.xml","form_type":"4"}},{"id":1759889,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-16T17:00:35.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023."}],"balance_after":34000,"derivative":{"exercise_price":4.16,"expiration_date":"2033-10-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-052879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805890/000120919123052879/doc4.xml","form_type":"4"}},{"id":1848923,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T21:25:40.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17060,"derivative":{"exercise_price":20.18,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":17060},"source":{"system":"sec-edgar","filing":"0000904454-23-000398","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445423000398/edgar.xml","form_type":"4"}},{"id":1848922,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:25:40.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":2290,"price":18.85,"value":43166.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.82 to $18.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22481,"source":{"system":"sec-edgar","filing":"0000904454-23-000398","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445423000398/edgar.xml","form_type":"4"}},{"id":1848921,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:25:40.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":24771,"source":{"system":"sec-edgar","filing":"0000904454-23-000398","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445423000398/edgar.xml","form_type":"4"}},{"id":1983053,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-01T21:09:34.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":389,"price":19.71,"value":7667.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.71 to $19.99. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16071,"source":{"system":"sec-edgar","filing":"0000899243-23-006571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000089924323006571/doc4.xml","form_type":"4"}},{"id":2047277,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-24T21:00:53.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":151233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":151233,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":151233},"source":{"system":"sec-edgar","filing":"0001214659-23-001042","document":"marketforms-58266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465923001042/marketforms-58266.xml","form_type":"4"}},{"id":2047276,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-24T21:00:53.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":89379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":151171,"source":{"system":"sec-edgar","filing":"0001214659-23-001042","document":"marketforms-58266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465923001042/marketforms-58266.xml","form_type":"4"}},{"id":2050461,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-19T14:45:56.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":3179,"price":42.3764,"value":134714.5756,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022."}],"balance_after":61792,"source":{"system":"sec-edgar","filing":"0001214659-23-000810","document":"marketforms-58203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465923000810/marketforms-58203.xml","form_type":"4"}},{"id":2078492,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-22T02:20:26.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":4616,"price":40.4142,"value":186551.9472,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1."}],"balance_after":64971,"source":{"system":"sec-edgar","filing":"0001214659-22-015198","document":"marketforms-57925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465922015198/marketforms-57925.xml","form_type":"4"}},{"id":2078491,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-22T02:20:26.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":35425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Performance Stock Units (\"PSUs\"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the \"Achievement Date\" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Meek's continuous service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64 shares acquired under the ESPP Purchase on 5/31/2022 and 41 shares acquired under the ESPP purchase on 11/30/2022."}],"balance_after":69587,"source":{"system":"sec-edgar","filing":"0001214659-22-015198","document":"marketforms-57925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465922015198/marketforms-57925.xml","form_type":"4"}},{"id":2209095,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:07:22.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.98,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-22-078797","document":"tm2220760-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922078797/tm2220760-6_4seq1.xml","form_type":"4"}},{"id":2209094,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:07:22.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":17307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":17307},"source":{"system":"sec-edgar","filing":"0001104659-22-078797","document":"tm2220760-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922078797/tm2220760-6_4seq1.xml","form_type":"4"}},{"id":2209093,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:07:22.000Z","date":"2022-07-11","kind":"disposition_to_issuer","acquired":false,"shares":27500,"price":2.2,"value":60500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078797","document":"tm2220760-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922078797/tm2220760-6_4seq1.xml","form_type":"4"}},{"id":2209092,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:07:22.000Z","date":"2022-07-07","kind":"other","acquired":false,"shares":22000,"price":2.2,"value":48400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078797","document":"tm2220760-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922078797/tm2220760-6_4seq1.xml","form_type":"4"}},{"id":2226753,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:22:15.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":17810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17810,"derivative":{"exercise_price":14.08,"expiration_date":"2032-06-15","underlying":"Ordinary Shares","underlying_shares":17810},"source":{"system":"sec-edgar","filing":"0000904454-22-000352","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445422000352/edgar.xml","form_type":"4"}},{"id":2226752,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-17T20:22:15.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":16460,"source":{"system":"sec-edgar","filing":"0000904454-22-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445422000352/edgar.xml","form_type":"4"}},{"id":2359435,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-03-02T22:34:05.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":602,"price":16.7,"value":10053.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $16.70 to $16.85.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7380,"source":{"system":"sec-edgar","filing":"0000904454-22-000215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445422000215/edgar.xml","form_type":"4"}},{"id":2368370,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-28T23:27:22.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":2645,"derivative":{"exercise_price":16.04,"expiration_date":"2032-02-24","underlying":"Ordinary Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000904454-22-000193","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445422000193/edgar.xml","form_type":"4"}},{"id":2368369,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-02-28T23:27:22.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":1534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":7982,"source":{"system":"sec-edgar","filing":"0000904454-22-000193","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445422000193/edgar.xml","form_type":"4"}},{"id":2393964,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:02:37.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":5769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 7,500 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 5,769 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date."}],"balance_after":5769,"derivative":{"exercise_price":2.44,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":5769},"source":{"system":"sec-edgar","filing":"0001104659-22-023774","document":"tm226724-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922023774/tm226724-5_4seq1.xml","form_type":"4"}},{"id":2393963,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:02:37.000Z","date":"2021-07-16","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 7,500 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 5,769 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-22-023774","document":"tm226724-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922023774/tm226724-5_4seq1.xml","form_type":"4"}},{"id":2393962,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:02:37.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":11538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 11,538 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date."}],"balance_after":11538,"derivative":{"exercise_price":2.44,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001104659-22-023774","document":"tm226724-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922023774/tm226724-5_4seq1.xml","form_type":"4"}},{"id":2393961,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:02:37.000Z","date":"2021-07-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on June 19, 2019. In exchange, the Reporting Person received a replacement option for 11,538 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the three years following the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-023774","document":"tm226724-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922023774/tm226724-5_4seq1.xml","form_type":"4"}},{"id":2431841,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T21:01:51.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service as a director of the Company."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001104659-22-005415","document":"tm223320-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465922005415/tm223320-4_4seq1.xml","form_type":"4"}},{"id":2433415,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-18T23:20:06.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":56433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":56433,"derivative":{"exercise_price":124.31,"expiration_date":"2032-01-13","underlying":"Common Stock","underlying_shares":56433},"source":{"system":"sec-edgar","filing":"0001214659-22-000844","document":"marketforms-55093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465922000844/marketforms-55093.xml","form_type":"4"}},{"id":2433414,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-18T23:20:06.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":34057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":34057,"source":{"system":"sec-edgar","filing":"0001214659-22-000844","document":"marketforms-55093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465922000844/marketforms-55093.xml","form_type":"4"}},{"id":2559596,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2021-09-24T21:11:07.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":150300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":150300,"derivative":{"exercise_price":167.1,"expiration_date":"2031-09-21","underlying":"Common Stock","underlying_shares":150300},"source":{"system":"sec-edgar","filing":"0001214659-21-009784","document":"marketforms-53882.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000121465921009784/marketforms-53882.xml","form_type":"4"}},{"id":2760450,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T14:34:40.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001104659-21-045913","document":"tm2111994-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465921045913/tm2111994-2_4seq1.xml","form_type":"4"}},{"id":2808157,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-04T18:58:55.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":505,"price":37.5,"value":18937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $36.76 to $37.50.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6448,"source":{"system":"sec-edgar","filing":"0000904454-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445421000288/edgar.xml","form_type":"4"}},{"id":2825392,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T21:00:28.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":4107,"derivative":{"exercise_price":37,"expiration_date":"2031-02-25","underlying":"Ordinary Shares","underlying_shares":4107},"source":{"system":"sec-edgar","filing":"0000904454-21-000254","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445421000254/edgar.xml","form_type":"4"}},{"id":2825391,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-01T21:00:28.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":2382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":6953,"source":{"system":"sec-edgar","filing":"0000904454-21-000254","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445421000254/edgar.xml","form_type":"4"}},{"id":3011434,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T20:33:01.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of the  next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":2.98,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-20-112661","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465920112661/a4.xml","form_type":"4"}},{"id":3237341,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-02T20:54:50.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":3620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":3620,"derivative":{"exercise_price":51.81,"expiration_date":"2030-02-27","underlying":"Ordinary Shares","underlying_shares":3620},"source":{"system":"sec-edgar","filing":"0000904454-20-000263","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445420000263/edgar.xml","form_type":"4"}},{"id":3237340,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-03-02T20:54:50.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":2063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":4571,"source":{"system":"sec-edgar","filing":"0000904454-20-000263","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445420000263/edgar.xml","form_type":"4"}},{"id":3297613,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-31T01:54:22.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":718,"price":62.2,"value":44659.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $62.20 to $62.21.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2508,"source":{"system":"sec-edgar","filing":"0000904454-20-000106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445420000106/edgar.xml","form_type":"4"}},{"id":3297612,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-31T01:54:22.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":4,"price":60.94,"value":243.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."}],"balance_after":3226,"source":{"system":"sec-edgar","filing":"0000904454-20-000106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445420000106/edgar.xml","form_type":"4"}},{"id":3480940,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T20:04:37.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in equal monthly installments over the three years following the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-037008","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465919037008/a4.xml","form_type":"4"}},{"id":3480939,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T20:04:37.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of the  next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":6.12,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-037008","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000110465919037008/a4.xml","form_type":"4"}},{"id":3683471,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T01:01:37.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":5295,"derivative":{"exercise_price":31.71,"expiration_date":"2029-01-25","underlying":"Ordinary Shares","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0000904454-19-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445419000107/edgar.xml","form_type":"4"}},{"id":3683470,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-30T01:01:37.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":3230,"source":{"system":"sec-edgar","filing":"0000904454-19-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445419000107/edgar.xml","form_type":"4"}},{"id":3890312,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":36708,"kind":"person","name":"Meek David D.","position":1,"cik":"0001555337","reported_name":"Meek David D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-18T14:31:34.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests over three years, with one-third vesting after twelve months from the date of grant and then one-twelfth every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":10000,"derivative":{"exercise_price":35.4,"expiration_date":"2028-06-14","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000904454-18-000433","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555337/000090445418000433/edgar.xml","form_type":"4"}}]}